Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HK2 | P52789 | 6/20 | 0.41 |
| ▸ | HK1 | P19367 | 5/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CD69 | Q07108 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metrizamide SCHEMBL1650311 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL16984723 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL24382 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL8678604 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL11048850 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL433082 | 0.87 | LMNA (0.76) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Metrizamide SCHEMBL17909957 | 0.87 | LMNA (0.75) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Iohexol SCHEMBL28086756 | 0.85 | LMNA (0.73) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| SCHEMBL18923658 | 0.84 | LMNA (0.72) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Ioxaglic Acid SCHEMBL28143605 | 0.84 | LMNA (0.70) | LMNAKDM4ECYP2D6CYP2C19HK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7056 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101973-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260125517-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-07 | — | — | US | claimed |
| US-12616681-B2 | Compositions and methods for treating renal injury | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-05-05 | — | — | US | claimed |
| WO-2026090138-A1 | ETHER-CONTAINING RADIOPAQUE POLYAMINO CROSSLINKERS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260108635-A1 | ETHER-CONTAINING RADIOPAQUE POLYAMINO CROSSLINKERS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-23 | — | — | US | claimed |
| EP-4683579-A1 | RELIEVE BACK PAIN AND/OR REBUILDING INTERVERTERAL DISC | Yeung, Jeffrey E. (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4656210-A1 | COMPOSITE HYDROGELS FOR TREATING VASCULAR DEFECTS | Covidien LP (US) | 2025-12-03 | — | — | EP | claimed |
| WO-2025226850-A1 | HYDROGEL COMPOSITIONS FOR TREATING VASCULAR DEFECTS | COVIDIEN LP (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250312520-A1 | INJECTABLE BIOPOLYMER COMPOSITIONS AND ASSOCIATED SYSTEMS AND METHODS | COVIDIEN LP | 2025-10-09 | — | — | US | claimed |
| US-12364793-B2 | Injectable biopolymer compositions and associated systems and methods | COVIDIEN LP (US) | 2025-07-22 | — | — | US | claimed |
| US-4795741-A | Compositions for therapeutic percutaneous embolization and the use thereof | BIOMATRIX, INC. (US) | 1989-01-03 | — | — | US | claimed |
| EP-0291177-A2 | Novel compositions for percutaneous embolization | Biomatrix, Inc. (US) | 1988-11-17 | — | — | EP | claimed |
| EP-0269520-A2 | Retrovirus of the type HIV-2, susceptible to provoke AIDS, and its antigenic and nucleic-acid constituents | INSTITUT PASTEUR (FR) | 1988-06-01 | — | — | EP | claimed |
| EP-0239425-A1 | Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof | INSTITUT PASTEUR (FR) | 1987-09-30 | — | — | EP | claimed |
| WO-1987004459-A1 | RETROVIRUS OF THE HIV-2 TYPE SUSCEPTIBLE OF INDUCING AIDS, AND ITS ANTIGENIC AND NUCLEIC CONSTITUENTS | INSTITUT PASTEUR (FR) | 1987-07-30 | — | — | WO | claimed |
| US-4640785-A | Separation of lymphocytes and monocytes from blood samples | BECTON DICKINSON AND COMPANY (US) | 1987-02-03 | — | — | US | claimed |
| EP-0190488-A1 | Separation of lymphocytes and monocytes from blood samples | Becton, Dickinson and Company (US) | 1986-08-13 | — | — | EP | claimed |
| US-4455292-A | Radiological contrast composition and methods | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1984-06-19 | — | — | US | claimed |
| US-4327734-A | Therapeutic method of use for miniature detachable balloon catheter | BECTON, DICKINSON AND COMPANY, A CORP. OF NJ | 1982-05-04 | — | — | US | claimed |
| US-4192859-A | MEDICAL DIAGNOSIS USING X-RAYS | E. R. SQUIBB & SONS, INC. (US) | 1980-03-11 | — | — | US | claimed |